NCT02917057View on ClinicalTrials.gov

Subanalyses of Elderly Type 2 Diabetes Patients or Type 2 Diabetes Patients With Renal Impairment

CompletedOBSERVATIONAL

Enrollment

6,024

Participants

Timeline

Start Date

August 1, 2015

Primary Completion Date

August 1, 2015

Study Completion Date

August 1, 2015

Conditions

Type 2 Diabetes

Interventions

DRUG

exenatide once weekly

Exenatide treatment in customary clinical care in the USA

DRUG

basal insulin

basal insulin tretament in the customary clinical care in USA

Trial Locations (1)

02215

Optum Epidemiology, Boston

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY